Swedish Orphan Biovitrum AB (publ) (BIOVF)
OTCMKTS · Delayed Price · Currency is USD
33.30
0.00 (0.00%)
At close: Oct 6, 2025
Swedish Orphan Biovitrum AB Employees
Swedish Orphan Biovitrum AB had 1,806 employees as of December 31, 2024. The number of employees increased by 66 or 3.79% compared to the previous year.
Employees
1,806
Change (1Y)
66
Growth (1Y)
3.79%
Revenue / Employee
$1,464,197
Profits / Employee
$237,355
Market Cap
10.92B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,806 | 66 | 3.79% |
| Dec 31, 2023 | 1,740 | 184 | 11.83% |
| Dec 31, 2022 | 1,556 | -3 | -0.19% |
| Dec 31, 2021 | 1,559 | 50 | 3.31% |
| Dec 31, 2020 | 1,509 | 174 | 13.03% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| American Oncology Network | 1,914 |
| Silence Therapeutics | 116 |
| Jushi Holdings | 1,234 |
| Nuo Therapeutics | 9 |
Swedish Orphan Biovitrum AB News
- 21 days ago - KalVista, Ionis/Sobi among latest to win EU nod for rare disease drugs - Seeking Alpha
- 21 days ago - Ionis Pharmaceuticals And Sobi Say EU Approves TRYNGOLZA For Familial Chylomicronemia Syndrome - Nasdaq
- 23 days ago - Swedish Orphan Biovitrum AB (Publ) (SWOBY) Discusses On NASP And Uncontrolled Gout Call (Transcript) - Seeking Alpha
- 24 days ago - Swedish Orphan Biovitrum AB (publ) - Special Call - Seeking Alpha
- 4 weeks ago - 10 stocks to consider if you want alternatives to the expensive S&P 500 - Market Watch
- 3 months ago - Swedish Orphan Biovitrum AB (publ) (BIOVF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Swedish Orphan Biovitrum AB (publ) 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 3 months ago - Swedish Orphan Biovitrum AB (BIOVF) Reports Strong Q2 Revenue Growth - GuruFocus